Bee Venom Treatment for Lyme Disease
July 23, 2000
Spread the Word to
Friends And Family
By Sharing this Article!
Email this article to a friend
Dr. Klinghardt uses 0.5 ml Bee-venom
form Canada (Michael Simics) in 2.5 ml Procaine and injects 0.5 ml procaine
in tender spot subcutaneously into the skin. It is relatively painless
and has an incredible effect in his Lyme Disease patients.
In some it lasts for 2 days and in others for 3-4
days. Dependent on the response he establishes a schedule: shots every
2-3 days. The client then learns to do their own injections and otherwise
follow the bee venom protocol that we have (bee sting kit etc.). Patients
start to feel much better very soon, their depression and fatigue lifts,
then their pain. It appears to be a great benefit!
Soon the gaps between shots increase until maybe
once every 19 days for maintanance in severe cases. If it doesnt work,
Babesia or Ehrlichiosis, Chlamydia pneumoniae, etc is the primary diagnosis
that needs to be treated.
He also uses a Lyme disease specific transfer factor
that is available from Chisholm Biological Labs 803-663-9618 X9777.
Below is an interesting study on the powerful effects
of bee venom on Lyme Disease:
Infect Dis 1997 Jul;25 Suppl 1:S48-51
The antimicrobial agent melittin
exhibits powerful in vitro inhibitory effects on the Lyme disease spirochete.
Lubke LL, Garon CF
Rocky Mountain Laboratories Microscopy Branch, National
Institute of Allergy and Infectious Diseases, National Institutes of Health,
Hamilton, Montana 59840, USA.
Borrelia burgdorferi has demonstrated a capacity to
resist the in-vitro effects of powerful eukaryotic and prokaryotic metabolic
inhibitors. However, treatment of laboratory cultures on Barbour-Stoenner-Kelly
medium with melittin, a 26-amino acid peptide contained in honeybee venom,
showed immediate and profound inhibitory effects when they were monitored
by darkfield microscopy, field emission scanning electron microscopy,
and optical density measurements.
Furthermore, at melittin concentrations as low as
100 microg/mL, virtually all spirochete motility ceased within seconds
of inhibitor addition. Ultrastructural examination of these spirochetes
by scanning electron microscopy revealed obvious alterations in the surface
envelope of the spirochetes. The extraordinary sensitivity of B. burgdorferi
to mellitin may provide both a research reagent useful in the study of
selective permeability in microorganisms and important clues to the development
of effective new drugs against lyme disease.